Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 294-302, July 2008

Efficacy and safety of amlodipine/valsartan compared with amlodipine monotherapy in patients with stage 2 hypertension: a randomized, double-blind, multicenter study: the EX-EFFeCTS Study

  • Maurizio Destro, MD

      Affiliations

    • Ospedale Arnaboldi, Azienda Ospedaliera di Pavia, Broni, Italy
    • Corresponding Author InformationCorresponding author: Maurizio Destro, MD, Ospedale Arnaboldi, Azienda Ospedaliera di Pavia, via Emilia 354, Broni, Italy. Tel: 00 39 0385 52214; fax: 00 39 0385 52214.
    • ,
  • Anders Luckow, MD

      Affiliations

    • General Practice Office, Viumvej, 10, Roslev, Denmark
    • ,
  • Mercedes Samson, MD

      Affiliations

    • Associated Pharmaceutical Research, Buena Park, California, USA
    • ,
  • Albert Kandra, PhD

      Affiliations

    • Biostatistics, Novartis AG, Basel, Switzerland
    • ,
  • Patrick Brunel, MD

      Affiliations

    • Clinical Development and Medical Affairs, Novartis AG, Basel, Switzerland

Received 29 October 2007; accepted 15 January 2008. published online 03 June 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This study was supported and funded by Novartis Pharma AG, Basel, Switzerland. Maurizio Destro has given talks at Scientific Meetings organized by Novartis. Albert Kandra and Patrick Brunel are employees of Novartis Pharma AG. EX-EFFeCTS in the title of the article stands for: EXforge EFFicacy and Control in Treatment of Stage 2 hypertension.

PII: S1933-1711(08)00012-0

doi:10.1016/j.jash.2008.01.004

Journal of the American Society of Hypertension
Volume 2, Issue 4 , Pages 294-302, July 2008

Article Tools

* Image Usage & Resolution